Zanamivir: an alternative translation.

AUTOR(ES)

Collier, J

RESUMO

This paper offers an alternative view to that given elsewhere regarding the value of zanamivir as an agent for treating patients who develop influenza symptoms. The position taken here has developed as a result of an analysis of the data that was undertaken by the journal Drug and Therapeutics Bulletin.

Documentos Relacionados

• Zanamivir: from drug design to the clinic.
• Alternative polyadenylation of the amyloid protein precursor mRNA regulates translation.
• Malpighi's De polypo cordis: an annotated translation.
• Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial
• Nascent peptide regulation of translation.